FY2025 · ended Dec 31, 2025 · Revenue $1.52B, +11.8% YoY · Filed Feb 24, 2026
Merit Medical Systems Inc (MMSI) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.5 billion and net income of $128.5 million. Free cash flow was $215.7 million. As of Sep 30, 2026 it held $503.6 million in cash and investments and $822.1 million in total debt.
Revenue (TTM)
$1.61B
+9.1% vs year-ago TTM
Net income (TTM)
$160.12M
+35.2% vs year-ago TTM
Operating cash flow (TTM)
$273.74M
+2.3% vs year-ago TTM
Free cash flow (TTM)
$203.59M
-1.6% vs year-ago TTM
EPS (TTM)
$2.66
+36.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
59.43M
+1.0% vs prior year
Net cash
$-318.51M
as of Sep 30, 2026
Operating margin
13.5%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MMSI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- UT
- Headquarters
- South Jordan, UT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 856982
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.3B | $1.2B | $1.1B |
| Operating income | $184.7M | $155.7M | $123.9M | $87.6M | $60.9M |
| Net income | $128.5M | $120.4M | $94.4M | $74.5M | $48.5M |
| Diluted EPS | $2.13 | $2.03 | $1.62 | $1.29 | $0.84 |
| Operating cash flow | $297.4M | $220.8M | $145.2M | $114.3M | $147.2M |
| Free cash flow | $215.7M | $185.7M | $110.9M | $69.3M | $119.3M |
| Total assets | $2.7B | $2.4B | $2.3B | $1.7B | $1.6B |
| Total liabilities | $1.1B | $1.0B | $1.1B | $519.6M | $608.5M |
| Stockholders' equity | $1.6B | $1.4B | $1.2B | $1.1B | $1.0B |
| Cash and investments | $446.4M | $376.7M | $587.0M | $58.4M | $67.8M |
| Total debt | $821.6M | $794.7M | $891.4M | $268.8M | $315.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 20, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
May 19, 2026 | May 13, 2026 |
All 1001 Merit Medical Systems Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.